Brown-Forman Confirms It Is Part of Consortium Led by STZ to Acquire Allied Domecq
More News related to AED
- UBS Securities Upgrades AED to Buy
- STZ Led Consortium Will Not Pursue Allied Domecq Bid
- STZ Confirms Consortium's Preliminary Approach to Allied Domecq
- Brown-Forman Confirms It Is Part of Consortium Led by STZ to Acquire Allied Domecq
- AED Gets Preliminary Approach from STZ Led Consortium
More News related to BF.B
- Davenport Upgrades Brown Forman (BF.B) to Buy; Current Weakness Created Buying Opportunity
- Morgan Stanley Initiates Coverage on Beverages (Alcoholic) Stocks
- David Moenning's Daily State of the Markets: 4/28
- Morning Movers 3/10: Citigroup (C) Up On Pandit Memo; AeroVironment (AVAV) Slammed On Guidance
- Brown-Forman (BF.B) Names Bareuther as Exec VP
More News related to STZ
- St. Pauli Girl Names Model Katarina Van Derham to Unprecedented Second Term
- Constellation Amends and Extends Revolving Credit Facility and a Portion of Term Loan; Intends to Call Senior Subordinated Notes
- Constellation Brands (STZ) Completes Gaymer Cider Sale for £45M
- Constellation Brands Completes Sale of U.K. Cider Business
- Morgan Stanley Initiates Coverage on Beverages (Alcoholic) Stocks
More News related to Rumors
- MetLife (MET) said to weigh using $8B in stock for a deal with AIG (AIG)
- Lawyer Says Toyota (TM) Recall to Cost More Than Estimated $2B
- Article Stirs Up Microsoft-for-Research in Motion Takeover Chatter (MSFT, RIMM)
UPDATE: Brown-Forman Corporation (NYSE: BF.b) confirmed today that it has joined a consortium led by Constellation Brands (NYSE: STZ) to consider a potential bid to acquire Allied Domecq (NYSE: AED). Other members of the consortium are Lion Capital (formerly Hicks Muse Europe) and Blackstone. Brown-Forman said there can be no assurances that an offer will be made by the consortium or that a transaction will result from this preliminary approach.
Related Categories
Mergers and AcquisitionsRumors
Stocks Mentioned
+0.22Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
